Capillary moderator in an osmotic delivery system for preventing backflow into the active agent reservoir
Details for Australian Patent Application No. 2005212365 (hide)
International Classifications
Event Publications
24 August 2006 PCT application entered the National Phase
PCT publication WO2005/077334 Priority application(s): WO2005/077334
1 May 2008 Assignment before Grant
Alza Corporation The application has been assigned to Intarcia Therapeutics, Inc.
2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005212369-Inhibition of factor B, the alternative complement pathway and methods related thereto
2005212363-Composition and method for use in cartilage affecting conditions
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser